Levulan Kerastick Kit
NDC 67308-101
Product Information
Levulan Kerastick (aminolevulinic acid hydrochloride) is a NDA-approved product labeled by Sun Pharmaceutical Industries, Inc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a kit. This product entry covers the primary NDC 67308-101 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 67308-101?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- AMINOLEVULINIC ACID HYDROCHLORIDE (UNII: V35KBM8JGR)
- AMINOLEVULINIC ACID (UNII: 88755TAZ87) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- WATER (UNII: 059QF0KO0R)
- LAURETH-4 (UNII: 6HQ855798J)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 762672 - aminolevulinic acid HCl 20 % Topical Solution
- RxCUI: 762672 - aminolevulinate 200 MG/ML Topical Solution
- RxCUI: 762672 - aminolevulinate 20 % Topical Solution
- RxCUI: 762674 - Levulan Kerastick 20 % Topical Solution
- RxCUI: 762674 - aminolevulinate 200 MG/ML Topical Solution [Levulan]
* Please review the full disclaimer at the bottom of this page.
Patient Education
Aminolevulinic Acid Topical
Aminolevulinic acid is used in combination with photodynamic therapy (PDT; special blue light) to treat actinic keratoses (small crusty or scaly bumps or horns on or under the skin that result from exposure to sunlight and can develop into skin cancer) of the face or scalp. Aminolevulinic acid is in a class of medications called photosensitizing agents. When aminolevulinic acid is activated by light, it damages the cells of actinic keratosis lesions.
[Learn More]
* Please review the full disclaimer at the bottom of this page.